Search Results By Year:
Showing 1 - 15 of 143 results
  • Doi SA, Salzman-Scott SA, Onitilo AA. Validation of the CoRE Questionnaire for Medical Journal Peer Review. Account Res. 2016 Jan 20;23(1):47-52.
    PubMed ID: 26192007
  • Burnside ES, Liu J, Wu Y, Onitilo AA, McCarty CA, Page CD, Peissig PL, Trentham-Dietz A, Kitchner T, Fan J, Yuan M. Comparing Mammography Abnormality Features to Genetic Variants in the Prediction of Breast Cancer in Women Recommended for Breast Biopsy. Acad Radiol. 2016 Jan 26;23(1):62-9.
    PubMed ID: 26514439
  • Asare M, Peppone LJ, Roscoe JA, Kleckner IR, Mustian KM, Heckler CE, Guido JJ, Sborov M, Bushunow P, Onitilo A, Kamen C. Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program. J Cancer Educ. 2016 Apr 21;
    PubMed ID: 27097806
  • Doi SA, Furuya-Kanamori L, Engel JM, Jamal MH, Stankowski RV, Barkun J, Onitilo AA. The McGill Brisbane Symptom Score in relation to survival in pancreatic adenocarcinoma: a validation study. Cancer Causes Control. 2016 May 26;
    PubMed ID: 27228990
  • Wu Y, Abbey CK, Liu J, Ong I, Peissig P, Onitilo AA, Fan J, Yuan M, Burnside ES. Discriminatory power of common genetic variants in personalized breast cancer diagnosis. Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9787
    PubMed ID: 27279675
  • Garg MK, Zhao F, Lee J, Sparano J, Palefsky J, Henry D, Wachsman W, Rajdev L, Aboulafia D, Mitchell E, Onitilo A, El-Rayes B, Nabbout N, Fitzgerald T, Mitsuyasu R, Benson AB, Kachnic LA. Radiation Therapy Compliance/Quality Assurance (QA) in 2 Phase 2 Trials of Cetuximab Plus Combined Modality Therapy (CMT) Including Chemotherapy and Radiation Therapy (RT) for Patients With Squamous Cell Carcinoma of the Anal Canal (SCCAC) (AMC045). Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S106-S107.
    PubMed ID: 27675537
  • Engel JM, Stankowski-Drengler TJ, Stankowski RV, Liang H, Doi SA. R., Onitilo AA. All-cause mortality is decreased in women undergoing annual mammography before breast cancer diagnosis. AJR Am J Roentgenol.. 2015 Apr;204(4):898-902.
    PubMed ID: 25794084
  • Depke JL, Boreen A, Onitilo AA. Navigating the Needs of Rural Women with Breast Cancer: A Breast Care Program. Clin Med Res. 2015 Dec;13(3-4):149-55.
    PubMed ID: 26056376
  • Onitilo AA, Engel JM, Stankowski RV, Doi SA. R.. Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy. Clinical Medicine & Research. 2015 Jun;13(2):65-73.
    PubMed ID: 25487237
  • Shanle EK, Onitilo AA, Huang W, Kim K, Zang C, Engel JM, Xu W, Wisinski KB. Prognostic significance of full-length estrogen receptor beta expression in stage I-III triple negative breast cancer. Am J Transl Res. 2015 Jul 15;7(7):1246-59.
    PubMed ID: 26328009
  • Liu J, Wu Y, Ong I, Page D, Peissig P, McCarty C, Onitilo AA, Burnside E. Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis. AMIA Jt Summits Transl Sci Proc.. 2015 Mar 25;2015 :107-11.
    PubMed ID: 26306250
  • Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. Journal of Medical Imaging. 2015 Aug 17;2(4):041005.
  • Braden AM, Stankowski RV, Engel JM, Onitilo AA. Breast Cancer Biomarkers: Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence. Curr Pharm Des. 2014 Dec;20(30):4879-98.
    PubMed ID: 24283956
  • Onitilo AA, Engel JM, Salzman SA, Stankowski RV, Doi SA. R.. A core-item reviewer evaluation (CoRE) system for manuscript peer review. Account Res. 2014;21(2):109-21.
    PubMed ID: 24228975
  • Stankowski-Drengler TJ, Stankowski RV, Engel JM, Onitilo AA. The Relationship of Type 2 Diabetes, Oral Diabetes Medications, and Insulin Therapy to Risk for Breast Cancer Curr Nutr Rep. 2014 Mar;3(1):1-8.